Wnt5A, a ligand of β-catenin-independent noncanonical Wnt pathways, has been identified as a promoter of SCLC neoplastic transformation and cell proliferation through activation of RHOA (Ras Homolog Family Member A). This evidence concerns the gene RHOA and small cell lung carcinoma.